PubMed · 1996 · 94 citations · 18 references
MedicineCardiologyNuclear MedicineCardiac Nuclear MedicineDiabetologyNuclear CardiologyCardiac ImagingCardiac Nuclear ImagingDiabetic NeuropathyMyocardial Perfusion ImagingDiabetic Neuropathy AssessmentDynamic Planar ImagingMetaiodobenzylguanidine ImagingMyocardial Tracer Uptake AssessmentMyocardial Uptake QuantificationQuantitative Uptake RatiosRegional Distribution PatternsRegional Uptake Analysis
UNLABELLED: Autonomic neuropathy along with cardiac denervation is one of the prognostic factors of diabetic patients. The aim of this study was to establish qualitative and quantitative assessment of diabetic cardiac denervation using [123I]metaiodobenzylguanidine (MIBG). METHODS: The study population consisted of 31 diabetic patients and 12 control subjects (C). Diabetic patients were classified into the following three groups according to their presentation of neuropathy: NO, without neuropathy; N1, mild neuropathy; N2, severe neuropathy. All subjects underwent triple-phase MIBG scanning, including dynamic planar imaging as well as early and delayed planar and SPECT imaging. Myocardial uptake ratios of MIBG and heart-to-mediastinum count ratios (H/M) were calculated as global uptake indices. Inferior-to-anterior count ratios and coefficients of variation were calculated as regional distribution indices. The washout rate of the inferior wall and whole myocardium were also studied. RESULTS: MIBG abnormalities were obvious in the inferior wall, which gradually spread to the adjacent segments. All indices of regional uptake showed a significant difference (p < 0.01) among the groups, while only the H/M of the late image showed significant differences in the two global uptake indices (p = 0.02). the washout rate of the inferior wall was enhanced with neuropathy. CONCLUSION: Diabetic neuropathy involves an MIBG abnormality in its early stages. Since this abnormality occurs in the inferior segment, an inferior-to-anterior count ratio, an index of regional MIBG uptake could be suitable for the evaluation of this condition because of its superior sensitivity.
18
Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
Pascal Merlet, Héric Valette, J.L. Dubois-Randé et al. · PubMed · 1992 · 583 citations
Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.
James C. Sisson, Brahm Shapiro, LAURA MEYERS et al. · PubMed · 1987 · 289 citations
Medicine, Pharmacology, Physiology +10
Quantitative Evaluation of Cardiac Parasympathetic Activity in Normal and Diabetic Man
Daniel Cook, Joel Brodsky, David A. Tice et al. · Diabetes · 1982 · 249 citations
Medicine, Cardiology, Physiology +15
M D Thames, H S Klopfenstein, François M. Abboud et al. · Circulation Research · 1978 · 225 citations · Full text